Results 21 to 30 of about 114,322 (384)
Cancer, 2023 Polypharmacy is common in older adults who are starting cancer treatment and is associated with an increased risk of potentially inappropriate medications (PIMs) and potential drug‐drug interactions (PDIs).
M. Mohamed +9 more
semanticscholar +1 more source
Thrombosis and Haemostasis, 2023 Background Polypharmacy may affect outcomes in patients with atrial fibrillation (AF) using non-vitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) due to interactions or reduced adherence, but comparative data are lacking ...
M. Grymonprez +4 more
semanticscholar +1 more source
Therapeutic Advances in Psychopharmacology, 2021 Aims: This cross-sectional pharmacoepidemiologic study examined the prevalence of polypharmacy and psychotropic polypharmacy among inpatients in a tertiary psychiatric hospital in Belgium.
Jeroen Govaerts +8 more
doaj +1 more source
BMC Primary Care, 2023 Background Older adults are more prone to increasing comorbidities and polypharmacy. Polypharmacy is associated with inappropriate prescribing and an increased risk of adverse effects.
George Doumat +5 more
semanticscholar +1 more source
An Increasing Trend in the Prevalence of Polypharmacy in Sweden: A Nationwide Register-Based Study
Frontiers in Pharmacology, 2020 AimPolypharmacy is becoming a global health problem. The aims of this study were to evaluate the temporal trends in the prevalence of polypharmacy in Sweden and to explore polypharmacy disparities by age, gender, education, and immigration status ...
Naiqi Zhang +7 more
doaj +1 more source
Effect of Oral Anticoagulants in Atrial Fibrillation Patients with Polypharmacy: A Meta-analysis
Thrombosis and Haemostasis, 2023 Background The aim of the present meta-analysis was to evaluate the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) versus vitamin K antagonists (VKAs) in atrial fibrillation (AF) patients with polypharmacy.
Yuxiang Zheng +5 more
semanticscholar +1 more source
DPSP: a multimodal deep learning framework for polypharmacy side effects prediction
Bioinformatics Advances, 2023 Motivation Because unanticipated drug–drug interactions (DDIs) can result in severe bodily harm, identifying the adverse effects of polypharmacy is one of the most important tasks in human health.
Raziyeh Masumshah, C. Eslahchi
semanticscholar +1 more source
Journal of Cachexia, Sarcopenia and Muscle, 2023 Polypharmacy in older adults is associated with multiple negative consequences that may affect muscular function, independently from the presence of medical conditions.
K. Prokopidis +13 more
semanticscholar +1 more source
Медицинский совет, 2021 The evolution of polypharmacy, which for many years consisted of quantifying concurrently prescribed drugs, has led to an qualitative description: “appropriate polypharmacy”, which may be beneficial for some patients, and “problematic polypharmacy ...
M. V. Leonova
doaj +1 more source
Frontiers in Pharmacology, 2023 Background: Older patients with dementia always need multiple drugs due to comorbidities and cognitive impairment, further complicating drug treatment and increasing the risk of potentially inappropriate medication.
Mengnan Zhao +4 more
semanticscholar +1 more source